Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: heart disease

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein  |  February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:OsteoarthritisResearchStem CellsTreatment

Strategic Thinking to Advance Rheumatology in the New Year

Audrey B. Uknis, MD  |  December 1, 2012

One of the first efforts this coming year will be the development of the American College of Rheumatology’s (ACR’s) 2013-2016 strategic plan

Filed under:Career DevelopmentCertificationEducation & TrainingLegislation & AdvocacyPresident's PerspectiveProfessional TopicsResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)CertificationEducationLegislationResearchRheumatology Research Foundation

Ethics in Patients’ End-of-Life Care Compound Therapeutic Challenges for Rheumatologists

C. Ronald MacKenzie, MD  |  December 1, 2012

While end-of-life decisions are not frequently encountered in day-to-day practice, rheumatologists should be familiar with the ethical challenges that may arise when caring for patients in the ICU

Filed under:EthicsFacilityPractice SupportProfessional TopicsQuality Assurance/Improvement Tagged with:end-of-lifeEthicsPainpatient carerheumatologisttransition

Depression in Rheumatoid Arthritis

Perry M. Nicassio, PhD, and Myra Irani, MA  |  November 1, 2012

Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

Filed under:ConditionsRheumatoid Arthritis Tagged with:Depressionpatient carepsychological disorderRheumatoid arthritisrheumatologistTreatment

How the Mayo Clinic Maximizes Learning Opportunities Through Social Media

Carol Patton  |  October 17, 2012

The Mayo Clinic’s Center for Social Media has become a social media resource for healthcare providers nationwide

Filed under:AppsCareer DevelopmentEducation & TrainingInformation TechnologyPractice SupportProfessional TopicsQuality Assurance/ImprovementTechnologyTechnology Tagged with:patient communicationPractice ManagementRheumatoid arthritisrheumatologistSocial MediaTechnology

Why We Are Advocates

James R. O’Dell, MD  |  September 5, 2012

Rheumatology advocacy efforts are paying off in 2012.

Filed under:Legislation & AdvocacyPresident's PerspectiveProfessional TopicsResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)LegislationResearchrheumatologistSGRSimple Tasks

Drug Updates: Lorcaserin, Acetaminophen, and More

Michele B. Kaufman, PharmD, BCGP  |  September 5, 2012

information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisRheumatoid Arthritis Tagged with:acetaminophenAnkylosing SpondylitisApprovalsBiologicsdrugFDAPipelinePsoriatic ArthritisrituximabSafetySteroids

The Happiest Specialty: Rheumatology Is #1!

James R. O’Dell, MD  |  July 10, 2012

Why are we all smiling, and how can we spread it around?

Filed under:Education & TrainingLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsResearch RheumWorkforce Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Career developmentPractice ManagementResearchrheumatologist

Coding Corner: Real-Life Rheumatology Note

Staff  |  July 9, 2012

A 46-year-old white female comes in for consultation on her arthritis pain.

Filed under:Billing/CodingPractice Support Tagged with:ArthritisBillingCodingEvaluation and Managementpatient carePractice Managementrheumatologist

ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA

Kathy Holliman  |  June 10, 2012

Detailed screening and treatment recommendations based on current evidence, extensive literature review.

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesFrom the CollegeRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugGlucocorticoidsGuidelinesLupusLupus nephritispatient careRheumatoid arthritisSystemic lupus erythematosustocilizumab

  • « Previous Page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 81
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences